Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/8615 |
Resumo: | Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to 2014. Methods: Cross-sectional, descriptive and quantitative approach research, through the collection of patient data attended at Hospital Universitário de Belém do Pará, between the years 2010 and 2014. Results: There was a predominance of males and a faixa age most affected was in the most productive phase (18 to 55 years old), secondary to teaching 94.1% were present in two cases, or time of diagnosis and initiation of treatment from 1 to 10 days appeared in the majority, how many years profile of drug resistance prevailing with rifampicin, isoniazid and streptomycin and most associated comorbidities foi or diabetes. Conclusion: There is a great complexity surrounding the aspects related to the treatment of Tuberculous Resistant to Multiple Medications, and that these factors contribute to the maintenance of two high teaching indices, as well as a scarcity of technologies such as rapid diagnosis of the teaching and availability of more alternatives of most effective treatment. The limiting factor of the investigation is due to the fact that it is a matter of medical records, there is no pattern of records in some, with little information. |
id |
UNIFEI_a9bf9ff2b5780e1ed40080b50d9c7af3 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/8615 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Evaluation of the clinical evolution of patients with Multidrug Resistant TuberculosisEvaluación de la evolución clínica de los pacientes con Tuberculosis MultirresistenteAvaliação da evolução clínica de pacientes portadores de Tuberculose Resistente a Múltiplos MedicamentosMultidrug resistant tuberculosisPublic healthAmazon. Tuberculosis multirresistente resistenteSalud públicaAmazonas.Tuberculose resistente a múltiplos medicamentosSaúde públicaAmazônia.Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to 2014. Methods: Cross-sectional, descriptive and quantitative approach research, through the collection of patient data attended at Hospital Universitário de Belém do Pará, between the years 2010 and 2014. Results: There was a predominance of males and a faixa age most affected was in the most productive phase (18 to 55 years old), secondary to teaching 94.1% were present in two cases, or time of diagnosis and initiation of treatment from 1 to 10 days appeared in the majority, how many years profile of drug resistance prevailing with rifampicin, isoniazid and streptomycin and most associated comorbidities foi or diabetes. Conclusion: There is a great complexity surrounding the aspects related to the treatment of Tuberculous Resistant to Multiple Medications, and that these factors contribute to the maintenance of two high teaching indices, as well as a scarcity of technologies such as rapid diagnosis of the teaching and availability of more alternatives of most effective treatment. The limiting factor of the investigation is due to the fact that it is a matter of medical records, there is no pattern of records in some, with little information.Objetivo: Evaluar la evolución clínica de pacientes con Tuberculosis Resistente a Múltiples Fármacos atendidos en un centro de referencia de la Amazonía, entre los años 2010 a 2014. Métodos: Abordaje transversal, descriptivo y cuantitativo, mediante la recolección de datos de pacientes atendidos en el Hospital Universitário de Belém do Pará, entre 2010 y 2014. Resultados: Predominó el sexo masculino y el grupo de edad más afectado fue el de la fase más productiva (18 a 55 años), la forma secundaria de la enfermedad estuvo presente en el 94,1% de los casos, el tiempo del diagnóstico y el inicio del tratamiento de 1 a 10 días apareció en la mayoría, con respecto al perfil de farmacorresistencia que prevaleció fueron rifampicina, isoniazida y estreptomicina y las comorbilidades más asociadas fue la diabetes. Conclusión: Existe una gran complejidad que involucra aspectos relacionados con el tratamiento de la Tuberculosis Múltiple Resistente a Fármacos, y que estos factores contribuyen al mantenimiento de altas tasas de enfermedad, como la escasez de tecnologías como el diagnóstico rápido de la enfermedad y la disponibilidad de más alternativas. métodos de tratamiento más eficaces. El factor limitante de la investigación fue el hecho de que se trataba de datos de registros médicos, no había patrón de registros y, en algunos, la escasez de información.Objetivo: Avaliar a evolução clínica de pacientes com Tuberculose Resistente a Múltiplos Medicamentos atendidos em um centro de referência na região Amazônica, entre os anos de 2010 a 2014. Métodos: Pesquisa transversal, descritiva e de abordagem quantitativa, através do levantamento de dados de pacientes atendidos no Hospital Universitário de Belém do Pará,entre os anos de 2010 e 2014. Resultados: Houve a predominância do sexo masculino e a faixa etária mais acometida foi a que está na fase mais produtiva (18 a 55 anos), a forma secundária da doença esteve presente em 94,1% dos casos, o tempo de diagnóstico e o início do tratamento de 1 a 10 dias apresentou-se na maioria, quanto ao perfil de resistências às drogas que prevaleceram foram a rifampicina, isoniazida e a estreptomicina e a comorbidades mais associada foi o diabetes. Conclusão: Existe uma grande complexidade envolvendo os aspectos relacionados ao tratamento de Tuberculose Resistente a Múltiplos Medicamentos, e que estes fatores contribuem para a manutenção dos altos índices da doença, como a escassez de tecnologias como o diagnóstico rápido da doença e a disponibilidade de mais alternativas de tratamento mais eficazes. O fator limitante da pesquisa se deu ao fato de se tratar de dados de prontuários, não houve um padrão de registros e em alguns, a escassez de informações.Research, Society and Development2020-09-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/861510.33448/rsd-v9i10.8615Research, Society and Development; Vol. 9 No. 10; e3609108615Research, Society and Development; Vol. 9 Núm. 10; e3609108615Research, Society and Development; v. 9 n. 10; e36091086152525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/8615/7691Copyright (c) 2020 Paula Sousa da Silva Rocha; Dayara de Nazaré Rosa de Carvalho; Dandara de Fátima Ribeiro Bendelaque; Felipe Costa Soares; Rafael Everton Assunção Ribeiro da Costa; Marcela Raíssa Asevedo Dergan; Rogéria de Sousa Rodrigues; Jucilene Luz Neves; Ana Carolina Marinho Pinheiro; Thais Neves de Souza; Susi dos Santos Barreto de Souza; Kathleen Heloisa Pinheiro Costa Neves; Ivonete Vieira Pereira Peixoto; Armando Sequeira Penela; Marcieni Ataíde Andrade; Marcos Valério Santos da Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRocha, Paula Sousa da Silva Carvalho, Dayara de Nazaré Rosa de Bendelaque, Dandara de Fátima Ribeiro Soares, Felipe CostaCosta, Rafael Everton Assunção Ribeiro da Dergan, Marcela Raíssa Asevedo Rodrigues, Rogéria de Sousa Neves, Jucilene Luz Pinheiro, Ana Carolina Marinho Souza, Thais Neves de Souza, Susi dos Santos Barreto deNeves, Kathleen Heloisa Pinheiro Costa Peixoto, Ivonete Vieira Pereira Penela, Armando SequeiraAndrade, Marcieni Ataíde Silva, Marcos Valério Santos da 2020-10-31T12:03:23Zoai:ojs.pkp.sfu.ca:article/8615Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:31:03.236999Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis Evaluación de la evolución clínica de los pacientes con Tuberculosis Multirresistente Avaliação da evolução clínica de pacientes portadores de Tuberculose Resistente a Múltiplos Medicamentos |
title |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis |
spellingShingle |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis Rocha, Paula Sousa da Silva Multidrug resistant tuberculosis Public health Amazon. Tuberculosis multirresistente resistente Salud pública Amazonas. Tuberculose resistente a múltiplos medicamentos Saúde pública Amazônia. |
title_short |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis |
title_full |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis |
title_fullStr |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis |
title_full_unstemmed |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis |
title_sort |
Evaluation of the clinical evolution of patients with Multidrug Resistant Tuberculosis |
author |
Rocha, Paula Sousa da Silva |
author_facet |
Rocha, Paula Sousa da Silva Carvalho, Dayara de Nazaré Rosa de Bendelaque, Dandara de Fátima Ribeiro Soares, Felipe Costa Costa, Rafael Everton Assunção Ribeiro da Dergan, Marcela Raíssa Asevedo Rodrigues, Rogéria de Sousa Neves, Jucilene Luz Pinheiro, Ana Carolina Marinho Souza, Thais Neves de Souza, Susi dos Santos Barreto de Neves, Kathleen Heloisa Pinheiro Costa Peixoto, Ivonete Vieira Pereira Penela, Armando Sequeira Andrade, Marcieni Ataíde Silva, Marcos Valério Santos da |
author_role |
author |
author2 |
Carvalho, Dayara de Nazaré Rosa de Bendelaque, Dandara de Fátima Ribeiro Soares, Felipe Costa Costa, Rafael Everton Assunção Ribeiro da Dergan, Marcela Raíssa Asevedo Rodrigues, Rogéria de Sousa Neves, Jucilene Luz Pinheiro, Ana Carolina Marinho Souza, Thais Neves de Souza, Susi dos Santos Barreto de Neves, Kathleen Heloisa Pinheiro Costa Peixoto, Ivonete Vieira Pereira Penela, Armando Sequeira Andrade, Marcieni Ataíde Silva, Marcos Valério Santos da |
author2_role |
author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Rocha, Paula Sousa da Silva Carvalho, Dayara de Nazaré Rosa de Bendelaque, Dandara de Fátima Ribeiro Soares, Felipe Costa Costa, Rafael Everton Assunção Ribeiro da Dergan, Marcela Raíssa Asevedo Rodrigues, Rogéria de Sousa Neves, Jucilene Luz Pinheiro, Ana Carolina Marinho Souza, Thais Neves de Souza, Susi dos Santos Barreto de Neves, Kathleen Heloisa Pinheiro Costa Peixoto, Ivonete Vieira Pereira Penela, Armando Sequeira Andrade, Marcieni Ataíde Silva, Marcos Valério Santos da |
dc.subject.por.fl_str_mv |
Multidrug resistant tuberculosis Public health Amazon. Tuberculosis multirresistente resistente Salud pública Amazonas. Tuberculose resistente a múltiplos medicamentos Saúde pública Amazônia. |
topic |
Multidrug resistant tuberculosis Public health Amazon. Tuberculosis multirresistente resistente Salud pública Amazonas. Tuberculose resistente a múltiplos medicamentos Saúde pública Amazônia. |
description |
Objective: To assess the clinical evolution of patients with Multiple Drug-Resistant Tuberculosis treated in a referral center in the Amazon region, between the years 2010 to 2014. Methods: Cross-sectional, descriptive and quantitative approach research, through the collection of patient data attended at Hospital Universitário de Belém do Pará, between the years 2010 and 2014. Results: There was a predominance of males and a faixa age most affected was in the most productive phase (18 to 55 years old), secondary to teaching 94.1% were present in two cases, or time of diagnosis and initiation of treatment from 1 to 10 days appeared in the majority, how many years profile of drug resistance prevailing with rifampicin, isoniazid and streptomycin and most associated comorbidities foi or diabetes. Conclusion: There is a great complexity surrounding the aspects related to the treatment of Tuberculous Resistant to Multiple Medications, and that these factors contribute to the maintenance of two high teaching indices, as well as a scarcity of technologies such as rapid diagnosis of the teaching and availability of more alternatives of most effective treatment. The limiting factor of the investigation is due to the fact that it is a matter of medical records, there is no pattern of records in some, with little information. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-09-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/8615 10.33448/rsd-v9i10.8615 |
url |
https://rsdjournal.org/index.php/rsd/article/view/8615 |
identifier_str_mv |
10.33448/rsd-v9i10.8615 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/8615/7691 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 9 No. 10; e3609108615 Research, Society and Development; Vol. 9 Núm. 10; e3609108615 Research, Society and Development; v. 9 n. 10; e3609108615 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052803824222208 |